In order to better understand the natural course, risk factors, treatments and reasons for the development of childhood interstitial lung disease (chILD), we will collect and analyse details of symptoms and quality of life, clinical data and also biological material in a Register and Biobank. In the long run, this Register will serve the improved understanding of the disease and will lead to the development of new and effective approaches to treatment.